Key Highlights

  • Rayonier Advanced Materials reported a USD 229 million net loss for the third quarter, equal to USD 3.40 a diluted share, and USD 221 million of that was non-cash impairments.
  • Ashland set a fiscal 2027 adjusted EBITDA outlook of USD 405 million to USD 435 million, compared with USD 385 million in fiscal 2026.
  • International Flavors & Fragrances grew third-quarter sales 4% to USD 1.942 billion, but a USD 236 million held-for-sale charge pushed continuing operations into a USD 127 million loss.
  • Innospec earned USD 1.29 per diluted share on Revenue of USD 473.6 million, while Operating Cash Flow shrank to USD 17.4 million from USD 39.1 million.

Rayonier Advanced Materials (NYSE:RYAM): Write-Downs and a Canadian Tariff Push the Result Into Red

Rayonier Advanced Materials (NYSE:RYAM) closed its third quarter, ended September 26, 2026, and reported on November 3, 2026. Both the loss from continuing operations and the overall net loss came to USD 229 million, a figure that includes USD 221 million of non-cash impairments. Stripping out those write-downs leaves a loss of USD 8 million, which is our own calculation and matches the figure the company also reports. Top-line sales advanced to USD 383 million, up from USD 353 million, and company-wide Adjusted EBITDA came to USD 52 million. High Purity Cellulose is the larger Business at USD 313 million of net sales and USD 43 million of operating income, while the Paperboard and High Yield Pulp segment posted an operating loss of USD 224 million. Following a 50% U.S. levy on Canadian paperboard that began August 22, 2026, the firm paused Temiscaming output on October 3, and monthly carrying costs run USD 2 million to USD 3 million. Net secured Leverage stood at 4.0 times, and Liquidity totaled USD 143 million. The Form 10-Q has not yet been filed, so these figures remain preliminary, and a strategic review is slated to wrap up in the first quarter of 2027 without any result promised.

Ashland (NYSE:ASH): Restructuring Costs and an Argentina Exit Weigh on the Quarter

Ashland (NYSE:ASH) reported fourth-quarter fiscal 2026 figures on November 3, 2026, covering the quarter that ended September 30, 2026. Sales increased to USD 498 million from USD 478 million. The Bottom Line was a USD 16 million loss, or USD 0.35 a share, against USD 32 million of profit the year before, while the loss from continuing operations totaled USD 17 million. Costs booked as unallocated and other climbed to USD 44 million, up from USD 11 million, which Ashland links to restructuring charges and a cumulative translation adjustment tied to winding down its Argentine entity. Stripping out intangibles amortization, the adjusted result came in at USD 52 million, or USD 1.12 a share, versus USD 1.08. Adjusted EBITDA rose 2% to USD 121 million. Life Sciences adjusted EBITDA climbed 16% to USD 64 million, and Personal Care advanced 14% to USD 49 million. Specialty Additives slipped to USD 20 million from USD 29 million, as weaker output at the Hopewell plant left fixed costs spread across fewer units. Net leverage sat at 2.3 times, and our derivation against the USD 385 million base puts implied fiscal 2027 adjusted EBITDA growth at about 5% to 13%.

International Flavors & Fragrances (NYSE:IFF): Held-for-Sale Accounting Outweighs 5% Volume Growth

International Flavors & Fragrances (NYSE:IFF) lodged its Quarterly Report for the period ended September 30, 2026, on November 3, 2026. Continuing-operations sales in the third quarter climbed 4% to USD 1.942 billion; group volume increased 5%, and each segment added to the total. The reported loss stemmed mainly from a USD 236 million charge on Assets classified as held for sale, tied to the Botanicals and Food Enhancements disposal group, plus a Goodwill write-down of USD 23 million tied to that same disposal group. Under that accounting, a held-for-sale asset is written to the lower of carrying value or sale price net of costs, so any gap hits Earnings right away. That left continuing operations in the red by USD 127 million, equal to a USD 0.50 loss per diluted share. Operating Margin dropped to 8.2% from 10.2%, while selling and administrative spending increased 11% to USD 387 million, with USD 28 million of extra regulatory outlays inside that figure. Shareholders bore a USD 55 million loss on an attributable basis, because discontinued operations contributed USD 72 million in the other direction. The Food Ingredients divestiture, signed May 29, 2026, is pencilled in for completion during Q2 2027 pending regulatory sign-off.

Innospec (NASDAQ:IOSP): Pricing Lifts Earnings, Cash Flow Lags Behind

Innospec (NASDAQ:IOSP) filed its July-to-September numbers on November 3, 2026, covering the period closing September 30. Sales moved up to USD 473.6 million from USD 441.9 million, with adjusted EBITDA at USD 51.4 million versus USD 44.2 million; GAAP and adjusted per-share earnings matched at USD 1.29. Twelve months back, GAAP per-share income stood at USD 0.52 because of property and intangible write-downs, whereas the adjusted figure was USD 1.12; adjusted growth works out to roughly 15% on our math. Performance Chemicals operating profit jumped 84% to USD 16.9 million, with pricing and product mix adding 12% even as volumes dropped 5%. Oilfield Services sales expanded 13%, reaching USD 112.4 million, though Leadership described the quarter-on-quarter trend as short of hopes, citing timing slippage in its older Middle East operations and pricier inputs. Operating cash generation shrank to USD 17.4 million from USD 39.1 million, and the cash pile ended at USD 251.9 million, down from USD 292.5 million at the close of 2025, with receivables and stock both expanding. A 94-cent semi-annual payout was approved, with cash going out November 25, 2026.

Where Things Stand

Charges explain much of the losses, though not all of them. Stripping out its impairments, Rayonier Advanced Materials (NYSE:RYAM) still ran a USD 8 million deficit, which points to some operational softness. Ashland (NYSE:ASH) lost USD 17 million mainly through restructuring and a translation item, yet it guided adjusted EBITDA higher. International Flavors & Fragrances (NYSE:IFF) recorded losses on planned disposals while volumes grew 5%. Innospec (NASDAQ:IOSP) looks the cleanest of the four, although cash flow trails earnings. The supplied material includes no trading volume data, so thin-trading risk for the smaller names cannot be assessed. This is information only, not a recommendation.